SCHEMBL29960432

SCHEMBL29960432

N#CCc1c(Cl)cccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.38
CSNK2A1 P68400 2/20 0.36
AKR1B1 P15121 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PIEZO1 Q92508 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CNR1 P21554 1/20 0.33
GRIA1 P42261 1/20 0.33
CACNG8 Q8WXS5 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KCNA5 P22460 1/20 0.32
KCNH2 Q12809 1/20 0.32
EGFR P00533 1/20 0.32
SRC P12931 1/20 0.32
HSD11B1 P28845 1/20 0.32
GAA P10253 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP1B1 Q16678 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5764019 1.00 TAAR1 (0.38) TAAR1CSNK2A1AKR1B1ALDH1A1PIEZO1
SCHEMBL779716 0.85 TAAR1 (0.44) TAAR1AKR1B1SMN1; SMN2CNR1GRIA1
SCHEMBL8130103 0.85 KDM4E (0.38) CSNK2A1ALDH1A1KDM4ETDP1EGFR
SCHEMBL1294116 0.78 GRIA1 (0.43) TAAR1AKR1B1ALDH1A1SMN1; SMN2CNR1
SCHEMBL958644 0.76 TAAR1 (0.55) TAAR1ALDH1A1SMN1; SMN2KDM4ETDP1
SCHEMBL31454540 0.76 DYRK1A (0.33) CSNK2A1KDM4ETDP1EGFRSRC
SCHEMBL31459423 0.76 TAAR1 (0.38) TAAR1AKR1B1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL12490313 0.76 DYRK1A (0.41) CSNK2A1ALDH1A1CNR1KDM4ETDP1
SCHEMBL534442 0.76 EED (0.37) TAAR1ALDH1A1SMN1; SMN2KDM4ETDP1
SCHEMBL11114860 0.76 TAAR1 (0.38) TAAR1AKR1B1ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed